Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer
Smit E, van Zandwijk N, Vincent A, Schellens J, Jörger M, Dingemans A, Eppinga P, Smit H, Biesma B, Burgers S, Groen H. Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009; 27:2038-45.
20.04.2009
Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer
20.04.2009
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009; 27:2038-45
Smit Egbert F, van Zandwijk Nico, Vincent Andrew, Schellens Jan H, Jörger Markus, Dingemans Anne-Marie C, Eppinga Pier, Smit Hans J M, Biesma Bonne, Burgers Sjaak A, Groen Harry J M
Weiter
